NORDIC BIOSCIENCE A/S
CVR 30799968 · Public limited company (A/S) · Active · Low risk
NORDIC BIOSCIENCE A/S is a Public limited company (A/S), founded on , based in Herlev. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.1% over the next 12 months, which is 0.0 times the average for Danish companies. 19 annual reports have been published, of which 4 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 131.2m and a net result of DKK 96.5m. CEO: Morten Asser Karsdal.
Bankruptcy risk for NORDIC BIOSCIENCE A/S
0.0 × the average (1.41%) · higher risk than 33% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 30799968
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (19 years)
- Address
- Herlev Hovedgade 205
2730 Herlev - Municipality
- Herlev
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 10.0m
- Employees
- 121 (2018)
- Auditor
- PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB
- Audit opted out
- No
Warning signs
| Annual reports filed late | 4 of 19 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 27.1% |
| Current ratio | 123% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 4 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 36 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | DKK 379.3m | DKK 324.9m | DKK 221.7m |
| Gross profit | DKK 292.1m | DKK 263.4m | DKK 164.6m |
| Net profit | DKK 96.5m | DKK 78.4m | DKK 28.9m |
| Equity | DKK 131.2m | DKK 111.3m | DKK 57.6m |
| Total assets | DKK 483.4m | DKK 425.4m | DKK 302.2m |
| Cash | DKK 20.7m | DKK 88.5m | – |
| Short-term debt | DKK 316.5m | DKK 273.5m | – |
| Avg. employees | 179 | 176 | – |
Latest annual report: Reporting class C, mellemstor virksomhed · auditor's statement: Revisionspåtegning · PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 168 | ||
| 1 Jan 2024 – 31 Dec 2024 | 190 | Late | |
| 1 Jan 2023 – 31 Dec 2023 | 190 | Late | |
| 1 Jan 2022 – 31 Dec 2022 | 181 | ||
| 1 Jan 2021 – 31 Dec 2021 | 161 | ||
| 1 Jan 2020 – 31 Dec 2020 | 186 | Late | |
| 1 Jan 2019 – 31 Dec 2019 | 252 | Late | |
| 1 Jan 2018 – 31 Dec 2018 | 159 | ||
| 1 Jan 2017 – 31 Dec 2017 | 99 | ||
| 1 Jan 2016 – 31 Dec 2016 | 153 | ||
| 1 Jan 2015 – 31 Dec 2015 | 155 | ||
| 1 Jan 2014 – 31 Dec 2014 | 159 | ||
| 1 Jan 2013 – 31 Dec 2013 | 176 | ||
| 1 Jan 2012 – 31 Dec 2012 | 162 | ||
| 1 Jan 2011 – 31 Dec 2011 | 177 | ||
| 1 Jan 2010 – 31 Dec 2010 | 157 | ||
| 1 Jan 2009 – 31 Dec 2009 | 152 | ||
| 1 Jan 2008 – 31 Dec 2008 | 158 | ||
| 1 Jan 2007 – 31 Dec 2007 | 157 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Morten Asser Karsdal | Current | |
| CEO | Claus Henrik Christiansen | ||
| CEO | Peter Degnboel Thostrup | ||
| Board | Claus Henrik Christiansen | Current | |
| Board | Thomas Nielsen | Current | |
| Board | Bente Juel Christiansen | Current | |
| Board | Morten Asser Karsdal | ||
| Owner (100%) | NORDIC BIOSCIENCE HOLDING A/S | Current | |
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB | Current | |
| Auditor | Brink Larse /Athos, Statsautoriseret Revisionsvirksomhed I/S | ||
| Auditor | ATHOS STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | AIDER Godkendt Revisionsaktieselskab | ||
| Auditor | DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB |
The CEOs' other companies
Morten Asser Karsdal – 13 other companies
- BIOMEDIQ A/S Active
- Clinical-Microbiomics A/S Active
- KARSDAL CONSULTING ApS Fusioneret
- NBCD A/S Active
- NORDIC BIOSCIENCE ASSAY DEVELOPMENT A/S Fusioneret
- NORDIC BIOSCIENCE CLINICAL STUDIES A/S Opløst
- NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S Opløst
- NORDIC BIOSCIENCE COMPOUND DEVELOPMENT A/S Fusioneret
- NORDIC BIOSCIENCE HOLDING A/S Active
- NORDIC BIOSCIENCE LABORATORY A/S Opløst
- Nordic Life Science Consulting ApS Active
- ProScion Ejendomme ApS Active
- Sanos A/S Active
Claus Henrik Christiansen – 44 other companies, of which 2 bankrupt
- DDD-DIAGNOSTIC A/S Bankrupt 13 Jun 2023
- MEJER & MUNKSGAARD A/S Bankrupt 20 Nov 2000
- 3D HOLDING A/S Opløst
- ARKA HOLDING ApS Opløst
- BIOMEDIQ A/S Active
- C.C. CONSULTING A/S Opløst
- C4PAIN ApS Active
- CACLAURIIS ApS Opløst
- CC & D ApS Opløst
- CCBR GROUP A/S Opløst
- CKL ApS Opløst
- CON-2009 HOLDING A/S Opløst
- Center for Clinical and Basic Research A/S Active
- GFKJUS 597 ApS Opløst
- HC NORDIC ApS Compulsorily dissolved
- IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S Opløst
- INVESTERINGSSELSKABET AF 20.12.1995. HERLEV ApS Opløst
- NBCD A/S Active
- NORDIC BIOSCIENCE ASSAY DEVELOPMENT A/S Fusioneret
- NORDIC BIOSCIENCE CLINICAL STUDIES A/S Opløst
- NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S Opløst
- NORDIC BIOSCIENCE COMPOUND DEVELOPMENT A/S Fusioneret
- NORDIC BIOSCIENCE HOLDING A/S Active
- NORDIC BIOSCIENCE LABORATORY A/S Opløst
- OSTEOMETER A/S Fusioneret
- OSTEOMETER MEDITECH A/S Opløst
- OSTEOPRESS ApS Opløst
- Oregano ApS Active
- PRICE INVENA ApS Active
- PRIDE PROTEOMICS A/S Fusioneret
Peter Degnboel Thostrup – 45 other companies, of which 6 bankrupt
- A-Z Search Denmark ApS Bankrupt 3 Jun 2020
- Datoselskabet af den 20. august 2024 A/S Bankrupt 21 Aug 2024
- East Metal Holding A/S Bankrupt 28 Aug 2024
- NN AX 1 ApS Bankrupt 4 Jun 2019
- NN AX 2 ApS Bankrupt 4 Jun 2019
- Nordic Fashion Brands A/S Bankrupt 27 Sep 2024
- AKTIESELSKABET AF DEN 24. MAJ 2004 Fusioneret
- AKTIESELSKABET TH. WESSEL & VETT. MAGASIN DU NORD Active
- BANG & OLUFSEN A/S Active
- BANG & OLUFSEN AUDIO VISUAL A/S Fusioneret
- BANG & OLUFSEN AUDIO VISUAL A/S Fusioneret
- BANG & OLUFSEN DANMARK A/S Active
- BANG & OLUFSEN EJENDOMME A/S Fusioneret
- BANG & OLUFSEN EXPANSION A/S Fusioneret
- BANG & OLUFSEN MULTIMEDIA A/S Fusioneret
- BANG & OLUFSEN NEW BUSINESS A/S Fusioneret
- BANG & OLUFSEN OPERATIONS A/S Active
- BANG & OLUFSEN PROPERTY A/S Fusioneret
- BANG & OLUFSEN TELECOM A/S Fusioneret
- BANG OG OLUFSEN FINANCE A/S Fusioneret
- BC GROUP A/S Fusioneret
- BITTE KAI RAND & CO. A/S Active
- Better Energy Holding A/S Active
- Copenhagen Cartel ApS Active
- H+H INTERNATIONAL A/S Active
- HOLMRIS B8 A/S Active
- Holmris Holding A/S Fusioneret
- ICEPOWER A/S Active
- IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S Opløst
- INFOR DANMARK A/S Active
Address history (3 moves)
| Herlev Hovedgade 205, 2730 Herlev | |
| Herlev Hovedgade 205, 2730 Herlev | |
| Herlev Hovedgade 207, 2730 Herlev | |
| Ballerup Byvej 222, 2750 Ballerup |
Employees per year
Other companies at the same address
- BRASIL CASA ApS Bankrupt
- BY CHRISTENSEN ApS Bankrupt
- CAPREAL ApS Bankrupt
- CAPREAL INVEST 1 ApS Bankrupt
- CAPREAL INVEST 2 ApS Bankrupt
- CAPREAL INVEST 3 ApS Bankrupt
- CASTLE HOLDING ApS Bankrupt
- CASTLE TALKING ApS Bankrupt
- EJENDOMSSELSKABET AMAGERBROGADE ApS Bankrupt
- KOMPLEMENTARSELSKABET NØRREBROGADE 155 ApS Bankrupt
- PENSOR TIETGENS HAVE ApS Bankrupt
- POMAN A/S Bankrupt
- TÆPPEFABRIKKEN AF 12. OKTOBER 1992 A/S Bankrupt
- VICH 2981 ApS Bankrupt
- VISION PLUS ApS Bankrupt
- DANSK TRADING ApS Opløst
- EJENDOMSANPARTSSELSKABET NYTORV 10, SLAGELSE Compulsorily dissolved
- EJENDOMSSELSKABET AMAGERBROGADE 111 ApS Compulsorily dissolved
- EJENDOMSSELSKABET AMAGERBROGADE 146-148 ApS Compulsorily dissolved
- EJENDOMSSELSKABET NORD ApS Compulsorily dissolved
- EJENDOMSSELSKABET NORD HOLDING ApS Compulsorily dissolved
- H. ERICHSEN AGENTUR/FABRIKATION ApS Opløst
- HERLEV HOVEDGADE 205 A/S Fusioneret
- I.B-L HANDEL ApS Fusioneret
- I.B-L HOLDING A/S Fusioneret
Similar companies in Herlev
- Symic OA ApS Herlev
- ProScion Ejendomme ApS Herlev
- BGI EUROPE A/S Herlev
- Strategic Partners A/S Herlev
- Sanos A/S Herlev
- NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S Herlev
- NORDIC BIOSCIENCE ASSAY DEVELOPMENT A/S Herlev
- NORDIC BIOSCIENCE COMPOUND DEVELOPMENT A/S Herlev
- NORDIC BIOSCIENCE CLINICAL STUDIES A/S Herlev
Questions and answers about NORDIC BIOSCIENCE A/S
Has NORDIC BIOSCIENCE A/S gone bankrupt?
No, NORDIC BIOSCIENCE A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of NORDIC BIOSCIENCE A/S?
Our model estimates a bankruptcy risk of 0.1% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the CEO of NORDIC BIOSCIENCE A/S?
Morten Asser Karsdal is the CEO of NORDIC BIOSCIENCE A/S.
Who is the auditor of NORDIC BIOSCIENCE A/S?
NORDIC BIOSCIENCE A/S most recently used PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB.
When was NORDIC BIOSCIENCE A/S founded?
NORDIC BIOSCIENCE A/S was founded on 13 August 2007.
What is the equity of NORDIC BIOSCIENCE A/S?
Equity was DKK 131.2m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.